WallStreetZenWallStreetZen

NASDAQ: DMRA
Damora Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Damora Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DMRA annual revenue was $0.0, with N/A growth year-over-year.

DMRA revenue history

Current Revenue
$0.0
Current Earnings
-$209.8M
Current Profit Margin
0%

Be the first to know when DMRA announces revenue.

DMRA Revenue History By Year

DMRA Yearly RevenueDMRA RevenueDMRA ChangeDMRA Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Damora Therapeutics Revenue FAQ

What was DMRA's revenue last quarter?

Damora Therapeutics (NASDAQ: DMRA) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Damora Therapeutics's revenue was $0.00.

What was Damora Therapeutics's revenue in 2025?

Damora Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Damora Therapeutics make in a day?

Based on Damora Therapeutics annual revenue for the past five years, DMRA makes an average of $0.00 per day.

What was Damora Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Damora Therapeutics's revenue has grown null year over year. Damora Therapeutics's revenue in the past year totaled $0.00.

How much does Damora Therapeutics make in a year?

Damora Therapeutics's revenue by year for the past five years is:
  • Damora Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Damora Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Damora Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Damora Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Damora Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.